Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Record Q1 results:

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 10, 2022 10:23am

134 Views

Post# 34416314

RE:Record Q1 results:

The boneheads say they had strong ebitda but then don't report. it.....

Qtr ending	Revenue	Net income	cfo	Adj ebitda	Gross margin	Cogs	ebitda margin
Dec 21	4,855,600	880,778	1,325,273	1,472,259	66.4%	1,633,742	30.3%
Sep 21	5,629,694	778,930	1,759,282	2,140,288	57.7%	2,383,971	38.0%
Jun 21	5,451,834	1,516,178	1,937,797	1,909,219	63.2%	2,006,020	35.0%
Mar 21	4,353,773	807,463	1,189,857	1,368,244	59.8%	1,748,668	31.4%
Dec 20	3,157,659	130,819	438,275	618,712	55.3%	1,410,361	19.6%
Sept 20	2,705,732	(4,982,997)	(35,228)	142,564	34.8%	1,764,777	5.3%
Jun 20	2,898,328	(440,233)	(143,203)	40,958	46.8%	1,542,733	1.4%
Mar 20	2,874,496	(219,030)	56,180	257,281	45.9%	1,553,883	9.0%
Dec 19	2,046,348	(585,265)	(330,619)	(116,481)	51.0%	1,002,614	(5.7%)
Sept 19	3,587,285	(48,816)	111,522	407,123	43.9%	2,011,207	11.3%
Jun 19	3,110,615	(191,322)	48,556	262,084	48.8%	1,591,292	8.4%
Mar 19	4,253,629	391,352	709,225	837,782	50.8%	2,092,132	19.7%
Dec18	2,460,812	(119,296)	103,780	311,817	52.4%	1,170,263	12.7%